Core Scientific, Inc.
CORZQ · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $554,639 | $25,549 | $3,474,215 | $3,204,527 |
| - Cash | $50,409 | $15,884 | $117,871 | $8,671 |
| + Debt | $865,545 | $37,731 | $818,806 | $40,289 |
| Enterprise Value | $1,369,775 | $47,396 | $4,175,150 | $3,236,145 |
| Revenue | $502,400 | $640,313 | $544,483 | $60,320 |
| % Growth | -21.5% | 17.6% | 802.7% | – |
| Gross Profit | $123,459 | $8,400 | $238,862 | $9,392 |
| % Margin | 24.6% | 1.3% | 43.9% | 15.6% |
| EBITDA | $114,323 | -$210,565 | $183,835 | $11,946 |
| % Margin | 22.8% | -32.9% | 33.8% | 19.8% |
| Net Income | -$246,487 | -$2,146,318 | $47,312 | -$12,206 |
| % Margin | -49.1% | -335.2% | 8.7% | -20.2% |
| EPS Diluted | -0.644 | -6.3 | 0.15 | -0.039 |
| % Growth | 89.8% | -4,300% | 489.6% | – |
| Operating Cash Flow | $65,114 | $205,187 | -$56,735 | -$23,765 |
| Capital Expenditures | -$16,994 | -$601,657 | -$424,544 | -$15,236 |
| Free Cash Flow | $48,120 | -$396,470 | -$481,279 | -$39,001 |